RNS Number : 7355G BSF Enterprise PLC 03 June 2026 3 June 2026 BSF Enterprise PLC Conditional Further Investment BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has conditionally placed 25,000,000 new ordinary shares in the Company ("Placing Shares") raising £500,000 before expenses at 2p per share in a placing ("Placing"). The proceeds of the Placing will be used to reinforce the Company's strategic business and growth plans, with the possibility of significant growth in shareholder value throughout 2026. Issue of Warrants In connection with the Placing, the Company will issue, on completion of the Placing, 1,500,000 warrants to Bowsprit Partners who arranged the Placing ("Broker Warrants"). The Broker Warrants shall be exercisable at 2p per Ordinary Share. The Broker Warrants are exercisable at any time within three years of Admission. Any issuance of shares under the Broker Warrants will be subject to available authority to issue shares being granted by the Company's shareholders at the forthcoming General Meeting. Admission Completion of the Placing is conditional on, inter alia, sufficient authority being granted and the Company's forthcoming General Meeting, the Placing Shares being admitted to listing on the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). Applications will be made to the FCA and to the London Stock Exchange for Admission in respect of all the Placing Shares proposed to be issued on completion of the Placing. It is expected that Admission will become effective, and that dealings in the Placing Shares are expected to commence on or around 8.00 a.m. on or around 12th June 2026. The rights attaching to the Placing Shares will rank pari passu with the existing ordinary shares of the Company. Total Voting Rights Following Admission, the Company's enlarged share capital will comprise 191,874,437 ordinary shares of 1 penny each. Therefore, the total number of voting rights in the Company will be 191,874,437. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310). END Engage with the BSF Enterprise management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here: https://bsfenterprise.com/link/yV0XQr For further enquiries, please visit www.bsfenterprise.com or contact: BSF Enterprise PLC Geoff Baker - Chairman Che Connon - CEO & Director We encourage all investors to share questions on this announcement via our investor website. https://bsfenterprise.com/s/a1f22b Bowsprit Partners John Treacy James Sheehan +44 (0)203 883 4430 ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43 About BSF Enterprise PLC BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather (via LGL), cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance alternatives to conventional materials, targeting global markets where provenance, ethics, and performance are increasingly prized by consumers and brands alike. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END IOEUPUBAQUPQPUP